https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32642 Wed 24 Nov 2021 15:52:35 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49608 Wed 14 Jun 2023 18:15:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47102 Wed 14 Dec 2022 09:51:28 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18836 Wed 11 Apr 2018 10:42:07 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31060 14 days) exposure to a PDA were compared to control infants without a PDA. Results: Thirty out of 189 infants had prolonged exposure to a PDA. The left heart remodeled to a larger and more spherical shape and thus significantly increased in volume. Most changes occurred in the first 4 weeks, plateaued, and then returned to control values. Systolic function and estimates of filling pressure increased and effective arterial elastance reduced with a PDA, however contractility was unchanged. Wall thickness increased after 4 weeks of increased volume exposure. Conclusion: The preterm PDA induces early and significant remodeling of the left heart. A compensated cardiac physiology was seen with preserved systolic function, suggesting adaptive rather than pathological remodeling changes with prolonged exposure to a PDA.]]> Wed 10 Nov 2021 15:14:02 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26058 Wed 09 Mar 2022 16:04:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29955 Wed 09 Feb 2022 15:56:13 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50848 Wed 09 Aug 2023 09:31:56 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54640 Wed 06 Mar 2024 15:11:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54626 Wed 06 Mar 2024 10:52:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52882 Tue 31 Oct 2023 10:45:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37167 Tue 25 Aug 2020 12:01:44 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49320 Tue 14 Nov 2023 14:26:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51649 70 years. Absolute rates of AVR increased from 3631 to 7277 with a significant 22% age-adjusted rise seen (1.9% increase per year (+0.26 per 100 000 per year; 95% confidence interval 0.19–0.34); P < 0.001). This trend was more pronounced in men than women and in those aged >80 years (+0.23 per 100 000 per year; P < 0.001). Proportion of mechanical AVR implanted fell from 38.4% to 8.6% (P < 0.001). A total of 2683 transcatheter aortic valve implantation (TAVI) procedures was performed in 2019, representing a 52% annual increase from 2014. BAV increased from 66 procedures in 2004 to 862 in 2019. Conclusion: Rates of AVR have increased significantly over the past 16 years, particularly in the elderly. Despite international guideline recommendations, fewer mechanical AVR are being used in younger cohorts. The uptake in TAVI rates might reflect evidence that suggests it is a safe alternative, at least in the medium term. BAV has also seen a resurgence during this time period.]]> Tue 12 Sep 2023 20:21:27 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51613 Tue 12 Sep 2023 13:49:03 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44306 Tue 11 Oct 2022 15:59:20 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43241 Thu 15 Sep 2022 10:10:25 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50188 Thu 06 Jul 2023 13:31:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50187 Thu 06 Jul 2023 13:17:40 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33112 Thu 04 Nov 2021 10:38:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:26847 Sat 24 Mar 2018 07:41:49 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52697 Mon 23 Oct 2023 14:05:29 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46019 Mon 21 Nov 2022 08:45:03 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41893 Mon 15 Aug 2022 12:02:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46963 R +0.42, +0.50, +0.47, +0.50, all P < 0.01), and transmitral Vti (R +0.37, P < 0.01). PVFT correlated negatively with E, EA, and Ee' (R -0.42, -0.47, -0.47, all P < 0.01). Conclusion: Left ventricle vortex formation can be analyzed with two-dimensional BSI and has the potential to complement existing parameters of cardiac health.]]> Mon 12 Dec 2022 15:23:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19628 Mon 10 Aug 2015 16:11:25 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32593 Fri 22 Jun 2018 14:57:22 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48470 Fri 17 Mar 2023 15:08:44 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44360 Fri 14 Oct 2022 08:44:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49374 Fri 12 May 2023 14:13:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49366 Fri 12 May 2023 12:42:14 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41821 2.2 mm. Conclusions: Nurses can lead the assessment of RA occlusion using ultrasound to enhance planning and care, including monitoring compression times to reduce RAO.]]> Fri 12 Aug 2022 12:52:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41547 Fri 05 Aug 2022 14:23:18 AEST ]]>